Flutiform FDA Approval Status
FDA Approved: No
Brand name: Flutiform
Generic name: fluticasone and formoterol
Dosage form: Inhalation Aerosol
Company: Vectura Group plc
Treatment for: Asthma
Flutiform (fluticasone and formoterol) metered dose inhaler is a corticosteroid and long-acting beta-agonist fixed-dose combination in development for the treatment of asthma.
Development timeline for Flutiform
| Date | Article |
|---|---|
| Jun 10, 2009 | SkyePharma Inc. Says FDA May Need More Flutiform Data |
| May 22, 2009 | Skyepharma plc: Flutiform NDA Accepted for Review |
| Aug 6, 2007 | SkyePharma PLC - Flutiform Progress Update |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
